Limitless Lung Vegan (Bronchogen)

Amount Per Capsule

Bronchogen (Ala-Glu-Asp-Leu) Vegan Bronchi Amino Acid – 10mg*

*Daily Value not established

Other ingredients:

Microcrystalline Cellulose, Gelatin and Calcium Stearate

Bronchi amino acid (plant derived)

Bronchogen Lung Peptide Bioregulator

Bronchogen is a synthesized peptide, specifically a tetrapeptide, that has shown promise in research for its potential therapeutic applications in respiratory diseases. Studies in animal models, particularly rats with chronic obstructive pulmonary disease (COPD), have demonstrated that Bronchogen can reduce inflammation, restore the structure and function of bronchial epithelium, and increase local immunity markers like secretory immunoglobulin A and surfactant protein B.

These findings suggest that Bronchogen may help in modulating inflammatory responses and promoting lung tissue regeneration, with potential benefits in treating respiratory conditions and possibly even age-related lung function decline.

Bronchogen Research

Bronchogen peptide bioregulator is composed of four amino acids: Ala-Glu-Asp-Leu (AEDL). This short peptide has garnered research interest for its potential effects on lung tissue and respiratory function. Studies have explored its role in cellular regulation, inflammation modulation, and age-related processes in the lungs.

DNA Interaction: Bronchogen may stabilize DNA structures in lung cells. This interaction could influence gene expression patterns, potentially activating genes involved in lung tissue maintenance and repair. Such effects might contribute to improved cellular function and resilience in respiratory tissues.

Epithelial Regeneration: Bronchogen may stimulate the growth and differentiation of lung epithelial cells. This process could aid in repairing damaged lung tissue and maintaining the integrity of the respiratory tract lining. Improved epithelial health might lead to better lung function and increased resistance to respiratory infections.

Surfactant Production: Bronchogen may increase surfactant production in the lungs. Surfactants reduce surface tension in the alveoli, facilitating easier breathing and gas exchange. Enhanced surfactant levels could potentially improve lung compliance and overall respiratory efficiency.

Anti-Inflammatory Action: Bronchogen may modulate inflammatory responses in lung tissue. By regulating pro-inflammatory factors, it could help mitigate chronic inflammation associated with various respiratory conditions. This anti-inflammatory effect might contribute to improved lung health and reduced symptom severity in certain respiratory disorders.

Geroprotective Properties: Bronchogen may exhibit geroprotective effects in lung tissue. It could potentially counteract age-related declines in lung function by reactivating senescent DNA and promoting cellular rejuvenation. These properties might slow the progression of age-associated respiratory changes and maintain lung health in older individuals.

Therapeutic Focus

• Chronic obstructive pulmonary disease (COPD)
• Respiratory diseases
• Inflammatory processes in the lungs
• DNA stabilization
• Immune and barrier function restoration in the lungs
• Prevention of inflammatory process progression

Studies of Interest

1. 1. Titova ON, Kuzubova NA, Lebedeva ES, Preobrazhenskaya TN, Surkova EA, Dvorakovskaya IV. [ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]. Ross Fiziol Zh Im I M Sechenova. 2017 Feb;103(2):201-8. Russian. PMID: 30199201.
   2. Monaselidze JR, Khavinson VKh, Gorgoshidze MZ, Khachidze DG, Lomidze EM, Jokhadze TA, Lezhava TA. Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability. Bull Exp Biol Med. 2011 Jan;150(3):375-7. doi: 10.1007/s10517-011-1146-x. PMID: 21240358.